Associated Papers
Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.
Di Giosaffatte N et al.
Breast (edinburgh, Scotland), 2025
[Identification of a novel NF1 mutation in a Chinese family affected with neurofibromatosis type I].
Zhang Q et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2019
Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer.
Wang X et al.
Cancer Prevention Research (philadelphia, Pa.), 2018
Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
Wang X et al.
Genes, Chromosomes & Cancer, 2018
The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.
Ruggieri M et al.
Clinical Genetics, 2015
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
Kiel C et al.
Molecular Systems Biology, 2014
24803665 (PubMed )
Supplement: MSB-10-5-727-s13.xls › energies
Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
Ko JM et al.
Pediatric Neurology, 2013
NF1 mutations and clinical spectrum in patients with spinal neurofibromas.
Kluwe L et al.
Journal of Medical Genetics, 2003
Select a paper to view details